Top Markets
#1 ADO Protocol ADO Protocol +194.62%
#2 Islamic Coin Islamic Coin +155.40%
#3 GoPlus Security GoPlus Security +44.15%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.36%
#6 Tutorial Tutorial +15.71%
#7 Wrapped NXM Wrapped NXM +14.49%
#8 Verus Coin Verus Coin +13.65%
#9 o1.exchange o1.exchange +12.74%
#10 Status Status +12.54%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Rank in Stocks #33736
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Share Price
$4.58
Last synced: 2025-05-09
Market Cap
$6.98M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade NeuroMetrix, Inc. (NURO)

Category

Healthcare
Operating Margin for NeuroMetrix, Inc. (NURO)
Operating Margin as of August 2026 TTM: -289.57%
According to NeuroMetrix, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is -289.57%. At the end of 2023 the company had an Operating Margin of -121.18%.
Operating Margin history for NeuroMetrix, Inc. from 2001 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -289.57% 0.00%
2024 -289.57% 138.96%
2023 -121.18% 111.00%
2022 -57.43% 107.48%
2021 -27.68% -2.50%
2020 -28.39% -77.18%
2019 -124.40% 62.85%
2018 -76.39% -0.20%
2017 -76.54% -39.47%
2016 -126.44% -30.48%
2015 -181.87% 14.32%
2014 -159.09% 14.12%
2013 -139.40% 5.37%
2012 -132.30% 37.51%
2011 -96.21% -22.74%
2010 -124.53% 367.10%
2009 -26.66% -57.12%
2008 -62.18% 173.92%
2007 -22.70% -538.22%
2006 5.18% 1,195.00%
2005 0.40% -102.03%
2004 -19.72% -49.14%
2003 -38.77% -66.11%
2002 -114.40% -56.22%
2001 -261.31% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
17.03% -100.06%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -100.08%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -100.06%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -100.07%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
28.09% -100.10%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.